Trademark Overview
On Monday, May 18, 2026, a trademark application was filed for POZEKEV with the United States Patent and Trademark Office. The USPTO has given the POZEKEV trademark a serial number of 99830523. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, May 18, 2026. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The POZEKEV trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity